Ibrutinib Suppresses Early Megakaryopoiesis but Enhances Proplatelet Formation

MLA

Huang, Jiansong, et al. “Ibrutinib Suppresses Early Megakaryopoiesis but Enhances Proplatelet Formation.” Thrombosis and Haemostasis, vol. 121, no. 2, Feb. 2021, pp. 192–205. EBSCOhost, https://doi.org/10.1055/s-0040-1716530.

APA

Huang, J., Huang, S., Ma, Z., Lin, X., Li, X., Huang, X., Wang, J., Ye, W., Li, Y., He, D., Yang, M., Pan, J., Ling, Q., Li, F., Mao, S., Wang, H., Wang, Y., & Jin, J. (2021). Ibrutinib Suppresses Early Megakaryopoiesis but Enhances Proplatelet Formation. Thrombosis and Haemostasis, 121(2), 192–205. https://doi.org/10.1055/s-0040-1716530

Chicago

Huang, Jiansong, Shujuan Huang, Zhixin Ma, Xiangjie Lin, Xia Li, Xin Huang, Jinghan Wang, et al. 2021. “Ibrutinib Suppresses Early Megakaryopoiesis but Enhances Proplatelet Formation.” Thrombosis and Haemostasis 121 (2): 192–205. doi:10.1055/s-0040-1716530.